Navigation Links
La Jolla Institute signs exclusive license agreement with Medimmune on major asthma discovery
Date:2/25/2009

SAN DIEGO (February 25, 2009) A major asthma discovery by a researcher at the La Jolla Institute for Allergy & Immunology has been licensed by MedImmune, a leading innovation-focused biotechnology company and wholly owned subsidiary of AstraZeneca PLC. MedImmune licensed the discovery to explore its use in the development of a potential biologics drug for treating asthma.

Under the agreement, MedImmune was granted exclusive intellectual property rights to the discovery, which demonstrated the pivotal role of a protein called the OX40 ligand in asthma. The finding was made by the laboratory of La Jolla Institute scientist Michael Croft, Ph.D., and marked a major milestone in asthma research.

Asthma is a chronic disease of the airways that can cause wheezing, coughing and difficulty breathing. It is the most common serious chronic disease of childhood and is the third-ranking cause of hospitalization among U.S. children under age 15.

More than 30 million Americans (or 11.2 percent of the population) reported having a history of asthma in 2005, including nine million children, according to the U.S. Centers for Disease Control and Prevention. More than 20 million Americans said they currently have the disease. The National Institutes of Health (NIH) estimates asthma-related health care costs in the U.S. at $14 billion annually.

La Jolla Institute leaders hailed the agreement as significant for asthma sufferers. "This agreement with MedImmune is an important first step towards the goal of translating some of Dr. Croft's groundbreaking work in the laboratory into an innovative therapy for improving the lives of asthma patients," said Mitchell Kronenberg, Ph.D., president and scientific director of the La Jolla Institute, a nonprofit biomedical research institute and international leader in immunology research.

Kronenberg added that such licensing arrangements are a central part of the mission of research inst
'/>"/>

Contact: Bonnie Ward
contact@liai.org
619-303-3160
La Jolla Institute for Allergy and Immunology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Palm Beach County wants to establish a Max Planck Institute in Florida
2. Midlands Consortium delighted to be chosen to host £1 billion energy institute
3. $22 million gift from Alfred Taubman launches new biomedical research institute
4. 3 Columbia University Medical Center faculty elected to Institute of Medicine
5. Stowers Institutes Xie Lab demonstrates dual intrinsic and extrinsic control of stem cell aging
6. Weizmann Institute scientists discover: A risk distribution law for evolution
7. Ludwig Institute for Cancer Research to set up its first Asian branch in Singapore
8. Baker Institute finds increased domestic production wont make US self-sufficient in natural gas
9. Lupus Research Institute strategy delivers $30 million in national funding
10. Stowers Institutes Hawley Lab identifies factors responsible for restart of meiotic cycle
11. Pew Institute for Ocean Science awards 5 fellowships in support of global marine conservation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2014)... – University of Utah engineers developed the first room-temperature ... produce electricity without needing to ignite the fuel. These ... electronics, off-grid power and sensors. , A study of ... Chemical Society journal ACS Catalysis . , Fuel ... between a fuel and an oxygen-rich source such as ...
(Date:11/4/2014)... November 4, 2014   ... growth   Fuel3D , a developer of ... funding round totaling $6.4 million (£4 million). This funding builds ... earlier this year and paves the way for the commercial ... The funding round was led by Chimera Partners and ...
(Date:11/3/2014)... LOS ANGELES , Nov. 3, 2014 /PRNewswire/ ... California -based life sciences company focused on ... eTNS system for the treatment of neurological ... Institute of Industrial Property has issued a Notice ... The patent application is co-owned by NeuroSigma and ...
Breaking Biology News(10 mins):Jet-fueled electricity at room temperature 2Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3
... ground by alternately squeezing and stretching muscles along the ... of contractions. Snails and sea cucumbers also use this ... gastrointestinal tracts operate by a similar action, squeezing muscles ... Now researchers at MIT, Harvard University and Seoul ...
... of the Pediatric Infectious Diseases Society ( JPIDS ... to date of the impact on reducing the days ... prospective-audit-with-feedback antibiotic stewardship program (ASP). The study utilized ... the Child Health Corporation of America. A companion ...
... , Fresno, Calif. Consuming grapes may help protect ... new research published in the Journal of Nutrition ... risk factors for heart disease in men with metabolic ... inflammation. Natural components found in grapes, known as ...
Cached Biology News:Soft autonomous robot inches along like an earthworm 2Soft autonomous robot inches along like an earthworm 3First antibiotic stewardship probed in the Journal of the Pediatric Infectious Diseases Society 2Eating grapes may help protect heart health in men with metabolic syndrome, new study suggests 2
(Date:11/24/2014)... , November 24, 2014   ... online on ScienceDirect   Elsevier , a ... services, is pleased to announce the launch of the latest ... Current Opinion in Food Science . ... will provide specialists with a new platform to keep up-to-date ...
(Date:11/24/2014)... November 24, 2014 Continental Clinical ... populations into clinical trials at its mid-Atlantic late-phase ... “Continental was created with the idea of closing ... fundamental role in medical advances," said Continental's CEO, ... experiment to the immortal cell line of Henrietta ...
(Date:11/24/2014)... Md. , Nov. 24, 2014  Spherix ... development company committed to the fostering and monetization ... Spherix v. VTech Telecommunications Ltd.,  Case No. 3:13-cv-03494-M ... Case No. 3:13-cv-03496-M, both in the United States ... Texas . On ...
(Date:11/22/2014)... PA and London (PRWEB) November 21, 2014 ... December will explore what comes next for ALS research and ... sites. , After the Ice Bucket Challenge: Where Does ... Cudkowicz, Date: Tuesday, 2 December 2014, Time: 1:30pm ... , Join expert speaker Dr. Merit Cudkowicz, Julianne Dorn ...
Breaking Biology Technology:Elsevier Announces Launch of New Journal: Current Opinion in Food Science 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 3At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 2At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 3Markman Hearing Held as Scheduled in VTech and Uniden Cases 2DrugDev Webinars in December to Explore What Comes Next for ALS Research and How We Can Make Life Easier for Clinical Sites 2
... ... sponsor for this year’s 4th Annual Orthopedic Design & Tradeshow (ODT) Expo, held at ... and staff will also be available to meet tradeshow attendees at booth #707 with ... offer to the medical device industry . , ...
... Development Group, Inc., a leading provider of clinical ... and medical device companies, today announced that the ... notified the Company that it has completed a ... related to revenue recognition, earnings, company operations and ...
... ... pressure to reduce costs and waste is driving global pharma-industry demand ... offer pharmaceutical companies a simple and secure way of providing pharmaceuticals ... test for leaks or recover product from rejected packages on an ...
Cached Biology Technology:Northeast Indiana Regional Partnership to Participate in 2009 Orthopedic Design & Technology Conference & Exhibition 2Northeast Indiana Regional Partnership to Participate in 2009 Orthopedic Design & Technology Conference & Exhibition 3Environmental & Economic Factors Drives Global Demand for Pharmaceutical leak Testing and Deblistering 2Environmental & Economic Factors Drives Global Demand for Pharmaceutical leak Testing and Deblistering 3
HLA II DG+DR+DP Monoclonal Antibody, Purified, Unconjugated, Clone: IQU9 This antibody is specific for the monomorphic determinant of the HLA Class II beta chains of the human MHC (28 kDa)....
Anti-gp120/160(SIV/mac239) Immunogen: gp120(SIV/mac239) protein (Genebank accession #M33262)...
Phospho-MEF2A(Thr312)...
Tube-O-DIALYZER Floats, small....
Biology Products: